Irish Journal of Medical Science

, Volume 179, Issue 2, pp 165–171 | Cite as

Short-course versus long-course neoadjuvant radiotherapy for lower rectal cancer: a systematic review

  • M. S. Sajid
  • M. R. S. Siddiqui
  • B. Kianifard
  • M. K. Baig
Review Article

Abstract

Objective

To analyse the efficacy of short-course (SCRT) versus long-course radiotherapy/chemoradiation (LCRT) as a neoadjuvant modality for the management of lower rectal cancer (LRC).

Methods

A systematic review of the literature was undertaken. Selected trials were analysed to generate a summative outcome.

Results

Seven trials on the efficacy of SCRT versus LCRT as a neoadjuvant modality for LRC encompassing 1,675 patients were retrieved but only 2 randomized trials on 396 patients qualified for this review. In both the fixed and random effects models, LCRT and SCRT were associated with equal overall survival, tumour recurrence, perioperative complications, sphincter preservation rate and toxicity.

Conclusions

SCRT and LCRT may be as effective as traditional LCRT in terms of overall survival, recurrence, perioperative complications, sphincter preservation and toxicity. Traditional neoadjuvant chemoradiation may continue to be used.

Keywords

Lower rectal cancer Neoadjuvant radiotherapy Short course Long course 

References

  1. 1.
    Sauer R, Becker H, Hohenberger W, Roedel C, Wittekind C, Fietkau R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740. doi:10.1056/NEJMoa040694 CrossRefPubMedGoogle Scholar
  2. 2.
    Glimelius B, Isacsson U, Jung B, Pahlman L (1997) Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose–response effect favoring preoperative treatment. Int J Radiat Oncol Biol Phys 37:281–287. doi:10.1016/S0360-3016(96)00510-X PubMedGoogle Scholar
  3. 3.
    Gerard J, Romestaig P, Bonnetain F, Conroy T, Bouche O, Closon Desjardins M (2005) Preoperative concurrent chemoradiotherapy (CT–RT) improves local control in T3–T4 rectal cancer; results of the FFCD 9203 randomized trial. Int J Radiat Oncol Biol Phys 63(Suppl 1):S2–S3. doi:10.1016/j.ijrobp.2005.07.010 AbstractGoogle Scholar
  4. 4.
    Bosset JF, Calais G, Mineur L, Maingon L, Radosevic-Jelic L, Daban A (2005) Preoperative radiation (PreopRT) in rectal cancer: effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial. 2005 ASCO Annual Meeting Proc. J Clin Oncol 23(Suppl 16):S247 (abstract). doi:10.1200/JCO.2005.02.113
  5. 5.
    Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T (2001) Preoperative radiotherapy combined with total mesorectal excision for respectable rectal cancer. N Engl J Med 345:638–646. doi:10.1056/NEJMoa010580 CrossRefPubMedGoogle Scholar
  6. 6.
    Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987. doi:10.1056/NEJM199704033361402 CrossRefGoogle Scholar
  7. 7.
    Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow of the Swedish Rectal Cancer Trial. J Clin Oncol 23:8697–8705. doi:10.1200/JCO.2005.02.9017 CrossRefPubMedGoogle Scholar
  8. 8.
    Marijnen CAM, Peetrs KCMJ, Putter H, Klein KE, Stiggelbout AM, Leer JWH (2004) Long term results, toxicity and quality of life in the TME trial. Radiother Oncol 73(Supple 1):S127–S128 (abstract)Google Scholar
  9. 9.
    Swedish Rectal Cancer Trial (1993) Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with respectable rectal carcinoma. Br J Surg 80:1333–1336. doi:10.1002/bjs.1800801040 CrossRefGoogle Scholar
  10. 10.
    Marijnen CAM, Kapiteijn E, van de Velde CH, Martijn H, Steup WH, Wiggers T (2002) Acute side effects and complications after short term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicentre randomized trial. J Clin Oncol 20:817–825. doi:10.1200/JCO.20.3.817 CrossRefPubMedGoogle Scholar
  11. 11.
    Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P (2004) Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Eur J Cancer 40:219–224. doi:10.1016/j.ejca.2003.09.032 CrossRefPubMedGoogle Scholar
  12. 12.
    Minsky BD (1997) Adjuvant therapy for rectal cancer—a good first step. N Engl J Med 336:1016–1017. doi:10.1056/NEJM199704033361410 EditorialCrossRefPubMedGoogle Scholar
  13. 13.
    Valentini V, Glimelius B, Minsky BD, Van Cutsem E, Bartelink H, Beets-Tan RGH (2005) The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for European consensus. Radiother Oncol 76:241–250. doi:10.1016/j.radonc.2005.07.001 CrossRefPubMedGoogle Scholar
  14. 14.
    Cox DJ, Stetz J, Pajak TF (1995) Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346. doi:10.1016/0360-3016(95)00060-C PubMedGoogle Scholar
  15. 15.
    Egger M, Smith GD, Altman DG (2006) DG Systematic reviews in healthcare. BMJ Publishing, LondonGoogle Scholar
  16. 16.
    Deeks JJ, Altman DG, Bradburn MJ (2001) Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Systemic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publication group, LondonGoogle Scholar
  17. 17.
    Dyomin A, Emelyanova T (2008) Preoperative radiotherapy vs preoperative chemoradiotherapy for rectal cancer. Proktologica 9:49Google Scholar
  18. 18.
    Ramsey S, Tepper JE (2007) Rectal cancer radiotherapy. Cancer J 13:204–209. doi:10.1097/PPO.0b013e318074def2 CrossRefPubMedGoogle Scholar
  19. 19.
    Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M, Polish Colorectal Study GROUP (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223. doi:10.1002/bjs.5506 CrossRefPubMedGoogle Scholar
  20. 20.
    Glimelius B, Pahlman L (2001) Preoperative radiotherapy for rectal cancer: hypofractionation with multiple fractions (15–25 Gy). Ann Ital Chir LXXII:539–547Google Scholar
  21. 21.
    Klenova A, Parvanova R, Georgiev R, Gesheva N (2006) Preoperative radiotherapy in rectal cancer: treatment of three different doses regimens. J BUON 11:161–166PubMedGoogle Scholar
  22. 22.
    Klenova A, Georgiev R, Kurtev P, Kurteva G (2007) Short versus conventional preoperative radiotherapy of rectal cancer: indications. J BUON 12:227–232PubMedGoogle Scholar
  23. 23.
    Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudelko M, Kryj, Oldezki J, Szmeja J, Sluziniak J, Serkies K, Klandy J, Pamucka M, Kukolowicz (2004) Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomized trail comparing short-term radiotherapy vs conventionally fractioned radiochemotherapy. Radiother Oncol 72:15–24. doi:10.1016/j.radonc.2003.12.006
  24. 24.
    Mendenhall WM, Million RR, Pfaff WW (1983) Pattern of recurrences in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 9:977–985PubMedGoogle Scholar
  25. 25.
    Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482. doi:10.1016/S0140-6736(86)91510-2 CrossRefPubMedGoogle Scholar
  26. 26.
    The Colorectal Cancer Collaborative Group (2001) Aduvant radiotherapy for rectal cancer: a systematic review of 8,507 patients from 22 randomized trials. Lancet 358:1291–130427. doi:10.1016/S0140-6736(01)06409-1 CrossRefGoogle Scholar
  27. 27.
    Janjan NA, Khoo VS, Pazdur R (1999) Tumour downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the MD Anderson Cancer Center experience. Int J Radiat Oncol Phys 44:1027–1038. doi:10.1016/S0360-3016(99)00099-1 CrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2009

Authors and Affiliations

  • M. S. Sajid
    • 1
  • M. R. S. Siddiqui
    • 1
  • B. Kianifard
    • 1
  • M. K. Baig
    • 1
  1. 1.Department of Colorectal SurgeryWorthing HospitalWorthingUK

Personalised recommendations